|Front Page Previous Story Next Story||
CSR Adds Four Appointees
Dr. Sally Amero has been named chief of the bioengineering sciences and technology integrated review group at the Center for Scientific Review. This is a new group slated to begin operations for the May 2004 council round. She currently serves as scientific review administrator for CSR's genome study section, and until recently served as a referral officer. Amero has been an assistant professor of molecular and cellular biochemistry at Loyola University of Chicago Stritch School of Medicine, where she studied RNA binding proteins with support from the American Cancer Society, the Potts Foundation and the National Science Foundation. She joined CSR in 1999 to coordinate the reviews for CSR's small business study section in genetics and genomics.
Dr. Eun Ah Cho has been named scientific review administrator for the new tumor microenvironment study section at the Center for Scientific Review. She recently participated in CSR's Review Internship Program. Cho received her Ph.D. in immunology from the University of Pennsylvania, where she studied the mechanisms of T-cell tolerance. In postdoctoral research at the University of Michigan, she studied the molecular mechanism of embryonic kidney development. Before coming to CSR, she was a staff research fellow at the NCI Laboratory of Cell Regulation and Carcinogenesis, where she worked for Dr. Seong-Jin Kim, studying the role of transforming growth factor beta-1 in cellular transformation.
Dr. Delia Tang has moved from NIDDK to the Center for Scientific Review to be the new scientific review administrator for the erythrocyte and leukocyte biology study section. She earned her M.D. from Beijing Medical University in China before beginning her research career at the Uniformed Services University of Health Sciences. Tang obtained an M.S. in pharmacology there. She subsequently joined NIDDK, where she developed methods to diagnose alpha-thalassemia, which is an inherited form of anemia. She became a senior fellow, conducting research on gene regulation for sickle cell anemia and hemoglobin pathology. Tang later became a staff scientist and managed research on gene regulation and expression related to hematological diseases.
David Whitmer has been appointed executive officer at the Center for Scientific Review. "He brings 10 years of NIH management experience to this important position," said Dr. Ellie Ehrenfeld, then CSR director. "He will be a tremendous asset as CSR works to manage its increasing workload and completes its reorganization." Whitmer holds a master's degree in public administration and political science from the University of South Florida. He started his NIH career as a presidential management intern, spending his first year as an administrative officer for the NCI Division of Cancer Etiology. He then moved to NCI's Office of the Director, where he was a management analyst coordinating management surveys and quantitative studies, producing NCI procedure and policy manuals, and developing automated systems for disseminating information on these new procedures and policies. Before coming to CSR, he was chief of the NHLBI Management Policy and Administrative Services Branch. He formulated and implemented NHLBI's administrative policies and procedures, and coordinated the delivery of administrative support services.
Up to Top